Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
about
Relationship between ultrasound bone parameters, lung function, and body mass index in healthy student population.Importance of Core Genome Functions for an Extreme Antibiotic Resistance Trait.Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii.Intensive care unit-acquired Acinetobacter baumannii infections in a Moroccan teaching hospital: epidemiology, risk factors and outcome.Trehalose, a temperature- and salt-induced solute with implications in pathobiology of Acinetobacter baumannii.Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.Crystal structure of a UDP-GlcNAc epimerase for surface polysaccharide biosynthesis in Acinetobacter baumannii.Unsaturated Fatty Acids Affect Quorum Sensing Communication System and Inhibit Motility and Biofilm Formation of Acinetobacter baumannii.The Complement Binding and Inhibitory Protein CbiA of Borrelia miyamotoi Degrades Extracellular Matrix Components by Interacting with Plasmin(ogen).Molecular Epidemiology of Emerging blaOXA-23-like and blaOXA-24-like -Carrying Acinetobacter baumannii in Taiwan.Substrate specificities and efflux efficiencies of RND efflux pumps of Acinetobacter baumannii.Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo.Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.Molecular characterization and clonal dynamics of nosocomial blaOXA-23 producing XDR Acinetobacter baumannii.Expanding the Current Knowledge About the Role of Interleukin-10 to Major Concerning BacteriaAminoglycoside Heteroresistance in Acinetobacter baumannii AB5075
P2860
Q38862568-002314D5-884A-4096-91A8-8B4BC18670D6Q47131617-1AF5575E-C9B4-4282-B788-3C7CE0D4A2DDQ47136007-F5E61D05-47BA-4EE3-A723-9B12463E9A11Q47138987-2E366ADD-339A-4EBC-A922-76EB053A9B72Q47619327-36D8235F-1239-4291-A516-B51405F4311DQ47721065-CF580BB1-F7C3-495D-BDB2-82B332FE18BDQ48203787-E498AB86-927F-4D70-89B8-DA0D831DAEBEQ49321181-C6731BCB-0FE5-45C4-B75A-6263CF0F0AA4Q49618867-369794AA-082B-4D0E-92B9-D4309DAF0C64Q50134172-545FD693-67AB-4BCF-9695-FBB844AB2B1DQ52718950-C82C2789-760E-4D97-B97C-4A3A1414DB2CQ53683184-29171524-649C-43F2-B543-42483C905594Q55109762-DFCFB1C9-FC50-4C8A-AEA3-5FEDDE0CED63Q55329968-B893B9DB-7A07-4C50-8E36-C4B987E868E8Q57073752-39B98864-CF41-4052-89BB-3C208EBDDF1BQ57169312-7CC13FA3-5D98-48E8-B704-3349D18CADD6
P2860
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Biology of Acinetobacter bauma ...... Prospective Treatment Options
@ast
Biology of Acinetobacter bauma ...... Prospective Treatment Options
@en
type
label
Biology of Acinetobacter bauma ...... Prospective Treatment Options
@ast
Biology of Acinetobacter bauma ...... Prospective Treatment Options
@en
prefLabel
Biology of Acinetobacter bauma ...... Prospective Treatment Options
@ast
Biology of Acinetobacter bauma ...... Prospective Treatment Options
@en
P2093
P2860
P921
P356
P1476
Biology of Acinetobacter bauma ...... Prospective Treatment Options
@en
P2093
Byeong Chul Jeong
Chang-Jun Cha
Chang-Ro Lee
Il Kwon Bae
Jung Hun Lee
Kwang Seung Park
Moonhee Park
Young Bae Kim
P2860
P356
10.3389/FCIMB.2017.00055
P50
P577
2017-03-13T00:00:00Z